New strategy could prevent T cell exhaustion and boost immunotherapy

A major pillar of cancer immunotherapy involves stimulating T cells, the specialized killers of the immune system, to attack tumors.

But this strategy has been undermined by the tendency of T cells to tire out before finishing the job.

When the cells reach a fatigued stage—called T cell exhaustion—they lose the ability to sustain the attack and keep cancer growth under control. ...